Sun Pharmaceutical Industries Ltd. - Research Center
524715 SUNPHARMA Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 20 | Mar ' 19 | Mar ' 18 | Mar ' 17 | Mar ' 16 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 12,531.93 | 10,303.21 | 9,006.25 | 7,683.96 | 7,614.46 |
| Expenses | |||||
| Material consumed | 4,942.40 | 4,109.54 | 4,041.34 | 3,726.42 | 3,481.75 |
| Manufacturing expenses | 394.74 | 407.28 | 376.17 | 349.23 | 370.48 |
| Personnel expenses | 1,702.77 | 1,571.34 | 1,625.00 | 1,499.88 | 1,480.51 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 2,780.37 | 2,458.79 | 1,985.48 | 1,994.46 | 2,716.70 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 9,820.28 | 8,546.95 | 8,027.99 | 7,569.99 | 8,049.44 |
| Operating profit | 2,711.65 | 1,756.26 | 978.26 | 113.97 | -434.98 |
| Other recurring income | 1,510.92 | 1,271.44 | 1,128.04 | 515.08 | 431.82 |
| Adjusted PBDIT | 4,222.57 | 3,027.70 | 2,106.30 | 629.05 | -3.16 |
| Financial expenses | 408.01 | 540.92 | 388.31 | 223.57 | 530.64 |
| Depreciation | 561.56 | 552.95 | 487.24 | 422.28 | 463.98 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 3,253.00 | 1,933.83 | 1,230.75 | -16.80 | -997.78 |
| Tax charges | 41.86 | -97.15 | -25.39 | 6.04 | 5.45 |
| Adjusted PAT | 3,211.14 | 2,030.98 | 1,256.14 | -22.84 | -1,003.23 |
| Non recurring items | -18.63 | -1,203.65 | -907.06 | -60.08 | -70.13 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 3,192.51 | 827.33 | 349.08 | -82.92 | -1,073.36 |
| Earnigs before appropriation | 15,577.12 | 12,864.33 | 12,835.08 | 12,734.90 | 12,478.84 |
| Equity dividend | 1,186.07 | 478.60 | 797.40 | 233.21 | 233.21 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | 192.89 | 0.56 | 0.34 | 7.47 | 7.47 |
| Retained earnings | 14,198.16 | 12,385.17 | 12,037.34 | 12,494.22 | 12,238.16 |
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis